Post-Op Shoe Market Expected to Reach $1.1 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Post-Op Shoe Market," The post-op shoe market size was valued at $634.50 million in 2021, and is estimated to reach $1.1 billion by 2031, growing at a CAGR of 5.1% from 2022 to 2031.

A post-op shoe is generally used by patients who undergo for surgery or has foot and ankle injuries. In addition, it is widely used in Europe and North America region followed by Asia-Pacific region. Some of the examples of post-op shoe are adjustable Darco med post-op surg shoe, Darco slimline cast boot, EZ Walking foot and ankle support cast boot, canvas rocker bottom cast shoe and pediatric classic post op shoe with buckle closure.

The post-op shoe market segmentation is done on the basis of type, end user, distribution channel and region. On the basis of type, the post-op shoe market is categorized into rigid sole, soft sole and semi-rigid sole. By end user, the market is divided into adult and children. On the basis of distribution channel, the post-op shoe market is segmented into medical & pharma store, specialty store and online retail. Region wise, the post-op shoe market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

On the basis of type, the semi-rigid post-op shoe segment was valued at $298.1 million in 2021 and is expected to reach $492.7 million by 2031 at a CAGR of 5.2%. This is majorly attributed to the varieties of post-op shoe offering in the market which tends to be one of the key post-op shoe market trends across the industries, aids in boosting the post-op shoe market demand.

On the basis of end user, the post-op shoe for adult is expected to grow at a CAGR of 5.2% during the forecast period. Adult segment shares largest revenue in this segment due to increase in the number foot ass well as ankle injuries incident among adult that likely contribute in post-op shoe market growth.

On the basis of distribution channel, the medical and pharma store segment was valued at $266.0 million in 2021 and is expected to reach $438.1 million by 2031 at a CAGR of 5.1%. Product offering in the medical and pharma store is one of the factors that contribute towards the growth expansion in of the market.

North America holds largest global post-op shoe market share across the globe and is projected to continue this trend during the forecast period. This is majorly attributed to rapid development towards technology to enhance the product in post-op shoe market. However, Asia-Pacific is predicted to have the most promising growth rate, owing to the development as well as lucrative offering in the post-op shoe market.

During the COVID-19 pandemic, supply chain disruption was a major issue for manufacturers, as countries closed their borders or raised trade barriers. As a result, manufacturers and exporters faced fierce competition to sell their products abroad. Moreover, as a result of subsequent lockdowns and retail store closures, on-premise sales at supermarkets and convenience stores have decreased, as people have practiced social distancing and avoided gatherings and & outings. Sales via online retail channels, on the other hand, significantly aided market penetration. All these factors had negative impact on post-op shoe market.

Key market strategies implemented by market players include product launches and geographic expansion. Product innovation is being prioritized by prominent market players in order to provide consumers with more innovative products. The key players in the global post-op shoe industry include A. Algeo Ltd., Bird and Cronin, LLC., Breg, Inc, DJO, LLC, DoctorschoiceDME., Henry Schein, Inc., Össur, Safte S.p.A., Steeper Inc., Chengli Medical Equipment Co.,Ltd.